Futura Medical plc
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Fut… Read more
Futura Medical plc (FAMDF) - Total Assets
Latest total assets as of June 2025: $5.49 Million USD
Based on the latest financial reports, Futura Medical plc (FAMDF) holds total assets worth $5.49 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Futura Medical plc - Total Assets Trend (2000–2024)
This chart illustrates how Futura Medical plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Futura Medical plc - Asset Composition Analysis
Current Asset Composition (December 2024)
Futura Medical plc's total assets of $5.49 Million consist of 69.9% current assets and 30.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 48.5% |
| Accounts Receivable | $1.27 Million | 9.3% |
| Inventory | $455.91K | 3.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Futura Medical plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Futura Medical plc's current assets represent 69.9% of total assets in 2024, a decrease from 99.4% in 2000.
- Cash Position: Cash and equivalents constituted 48.5% of total assets in 2024, down from 86.3% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 9.3% of total assets.
Futura Medical plc Competitors by Total Assets
Key competitors of Futura Medical plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Futura Medical plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Futura Medical plc generates 1.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Futura Medical plc generates $9.51 in net profit.
Futura Medical plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.92 | 3.75 | 3.17 |
| Quick Ratio | 1.90 | 3.75 | 3.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.24 Million | $ 4.56 Million | $ 2.07 Million |
Futura Medical plc - Advanced Valuation Insights
This section examines the relationship between Futura Medical plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.71 |
| Latest Market Cap to Assets Ratio | 0.47 |
| Asset Growth Rate (YoY) | 15.0% |
| Total Assets | $13.59 Million |
| Market Capitalization | $6.35 Million USD |
Valuation Analysis
Below Book Valuation: The market values Futura Medical plc's assets below their book value (0.47 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Futura Medical plc's assets grew by 15.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Futura Medical plc (2000–2024)
The table below shows the annual total assets of Futura Medical plc from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $13.59 Million | +15.01% |
| 2023-12-31 | $11.82 Million | +82.56% |
| 2022-12-31 | $6.47 Million | -45.16% |
| 2021-12-31 | $11.80 Million | +628.54% |
| 2020-12-31 | $1.62 Million | -66.95% |
| 2019-12-31 | $4.90 Million | -54.94% |
| 2018-12-31 | $10.88 Million | +13.25% |
| 2017-12-31 | $9.60 Million | -28.53% |
| 2016-12-31 | $13.44 Million | +143.67% |
| 2015-12-31 | $5.52 Million | -46.61% |
| 2014-12-31 | $10.33 Million | +604.73% |
| 2013-12-31 | $1.47 Million | -54.31% |
| 2012-12-31 | $3.21 Million | +8.68% |
| 2011-12-31 | $2.95 Million | +180.34% |
| 2010-12-31 | $1.05 Million | -49.30% |
| 2009-12-31 | $2.08 Million | +100.10% |
| 2008-12-31 | $1.04 Million | -66.39% |
| 2007-12-31 | $3.09 Million | -26.21% |
| 2006-12-31 | $4.18 Million | +88.77% |
| 2005-12-31 | $2.22 Million | -44.20% |
| 2004-12-31 | $3.97 Million | +53.46% |
| 2003-12-31 | $2.59 Million | +46.60% |
| 2002-12-31 | $1.77 Million | -21.89% |
| 2001-12-31 | $2.26 Million | +572.92% |
| 2000-12-31 | $336.00K | -- |